David Armstrong - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Professor, Medicine, Faculty of Health Sciences
Member, Farncombe Family Digestive Health Research Institute, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Contact
View All

selected scholarly activity

chapters
- The Stomach. 31-65. 2022
- Duodenal Ulcer. 90-102. 2020
- Actors, Patients and Agency: A Recent History. 7-18. 2014
- Epidemiology of GERD, Barrett's Esophagus and Esophageal Cancer. 119-134. 2014
- Epidemiology of GERD, Barrett's esophagus and esophageal cancer. 121-134. 2014
- Bariatric Surgery and Its Effects on Heart Rate Variability. 279-299. 2013
- Bariatric Surgery and Its Effects on Heart Rate Variability. 279-300. 2012
- Evaluation as an Innovative Health Technology. 232-241. 2006
conferences
- SIMILAR RATE OF POST-COVID-19 SYMPTOMS IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF AN INTERNATIONAL CROSS-SECTIONAL STUDY. Gastroenterology. S1033-S1034. 2023
- THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSSSECTIONAL STUDY. Gastroenterology. S1034-S1034. 2023
- Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial. American Journal of Gastroenterology. S272-S273. 2022
- 59 A Novel, Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Oesophagus Related Neoplasia (Born): The Born Project. Gastrointestinal Endoscopy. AB48-AB48. 2017
- ANTIGLIADIN ANTIBODIES PREDICT THE SYMPTOMATIC RESPONSE TO GLUTEN-FREE DIET AND IMPROVEMENT IN GASTROINTESTINAL MOTILITY IN IBS PATIENTS. Gastroenterology. S45-S45. 2017
- Gluten Free Diet Improves Upper GI Symptoms and Promotes Changes in Gastric Emptying in IBS Patients with Functional Dyspepsia. Gastroenterology. S939-S939. 2017
- EFFECT OF DIET ON GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) STRATIFIED BY ANTIGLIADIN (AGA) ANTIBODIES. Annals of Nutrition and Metabolism. 1018-1018. 2017
- ROLE OF EMPIRIC ANTI-REFLUX THERAPY IN PEDIATRIC OTITIS MEDIA WITH EFFUSION - A PILOT STUDY. European Journal of Pediatrics. 1658-1658. 2016
- Post Analysis of Polyps in 9 Short Bowel Syndrome Patients Treated with Teduglutide. American Journal of Gastroenterology. S241-S241. 2016
- Tu1138 The BORN Project: A Novel, Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Oesophagus Related Neoplasia (BORN). Gastrointestinal Endoscopy. AB550-AB550. 2016
- Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies. Gastroenterology. S743-S744. 2016
- Sa1085 Telephone vs. Clinic Follow-Up in the Management of Patients With Inflammatory Bowel Disease: A Nurse Practitioner Led Study. Gastroenterology. S235-S235. 2016
- Su1897 Inflammation-Related Differences in Mucosa-Associated Microbiota and Paracellular Permeability in Crohn's Colitis. Gastroenterology. S582-S582. 2016
- Anxiety and depression may lead to poor health-related quality of life in patients with inflammatory bowel disease. Journal of Crohn's and Colitis. S154-S154. 2016
- Living with inflammatory bowel disease: results from focus group. Journal of Crohn's and Colitis. S499-S500. 2016
- P-079 YI The Association Between Anxiety and Depression and Health Related Quality of Life in Patients with Inflammatory Bowel Disease (IBD). Inflammatory Bowel Diseases. S34-S34. 2016
- P-231 YI Patient Experience Living with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. S79-S79. 2016
- Telephone vs clinic follow-up in the management of patients with inflammatory bowel disease: a nurse practitioner-led study. Journal of Crohn's and Colitis. S495-S495. 2016
- A National Survey and Needs Assessment on Choices of Therapeutic Agents for Chronic Idiopathic Constipation and Constipation Predominant Irritable Bowel Syndrome: A Canadian Perspective. American Journal of Gastroenterology. S758-S758. 2015
- Evaluation of a Novel, Icon-Based Symptom Assessment Tool for Gastroenterology. American Journal of Gastroenterology. S754-S755. 2015
- Mucosal Features of Colonic Crohn’s Disease Determined by Confocal Laser Endomicroscopy (CLE): An Inter-observer Agreement Study. American Journal of Gastroenterology. S507-S507. 2014
- A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis.. Gastroenterology. S159-S159. 2014
- Dermatological Complications of Anti-TNF-alpha Therapy in Crohn's Disease. Gastroenterology. S583-S583. 2014
- Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia. Gastroenterology. S470-S471. 2014
- Integrating Data from EHRs to Enhance Clinical Decision Making: The Inflammatory Bowel Disease Case. Proceedings of the IEEE Symposium on Computer-Based Medical Systems. 531-+. 2014
- Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial. Gastroenterology. S902-S902. 2014
- P309 Transition experience from inpatient to ambulatory IBD care: Results of a pilot study. Journal of Crohn's and Colitis. S193-S194. 2014
- Psychosocial Characteristics of Patients With IBD: Experience From the Mcmaster Interdisciplinary Clinic. Gastroenterology. S651-S651. 2013
- Does Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease Impact Clinical Management? A Canadian Experience.. Inflammatory Bowel Diseases. S82-S83. 2012
- Current Management Practices for Moderate-To-Severe Gastroesophageal Reflux Disease (GERD) in Canadian Primary Care Practice. American Journal of Gastroenterology. S594-S595. 2012
- Point Prevalence of Malnutrition Risk in a Tertiary Care Academic Hospital. American Journal of Gastroenterology. S137-S138. 2012
- Communicating Gastrointestinal (GI) Symptoms: the Patient's Challenge. Gastroenterology. S579-S579. 2012
- Why doesn't Crohn's Disease DNA-based risk information motivate quitting? A qualitative study. Psychology and Health. 141-141. 2012
- Interdisciplinary, prompt access IBD clinic: The hamilton health science experience. Inflammatory Bowel Diseases. S7-S7. 2011
- Barrett's Dysplasia Cancer Task Force - Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus. Gastroenterology. S178-S178. 2011
- Integrated CMOS sensors for fluorescence spectroscopy and imaging. 2009 Asia Communications and Photonics Conference and Exhibition, ACP 2009. 2009
- Epidemiology of Blood Stream Infections in a Hospital-Based, Home Parenteral Nutrition Program. American Journal of Gastroenterology. S108-S108. 2009
- Improvement in Sleep Disturbance in Patients with Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care. Gastroenterology. A439-A440. 2009
- Information Needs of Digestive Disease Patients: the Patient Education Needs Survey (PENS). Gastroenterology. A638-A638. 2009
- Resolution of Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care. Gastroenterology. A435-A435. 2009
- The Gain in Quality-Adjusted Life Years By Switching to Esomeprazole in Those with Persistent GERD Symptoms in Primary Care: EncomPASS - a Cluster-Randomized Trial. Gastroenterology. A439-A439. 2009
- Integrated CMOS Sensors for Fluorescence Spectroscopy and Imaging. Optics InfoBase Conference Papers. 2009
- Integrated CMOS sensors for fluorescence spectroscopy and imaging. Optics InfoBase Conference Papers. 1-2. 2009
- Predictors of bowel preparation quality in patients undergoing colonoscopy - a preliminary analysis. Gastroenterology. A319-A319. 2008
- Immunohistochemical demonstration of esophageal dilated intercellular spaces (DIS) in squamous mucosa. Modern Pathology. 133A-134A. 2008
- Immunohistochemical demonstration of esophageal dilated intercellular spaces (DIS) in squamous mucosa. Laboratory Investigation. 133A-134A. 2008
- Symptom Assessment. Journal of Clinical Gastroenterology. S184-S192. 2007
- Endoscopic Ultrasound: A Meta-Analysis of Test Performance in Suspected Choledocholithiasis. Gastrointestinal Endoscopy. AB360-AB360. 2007
- Endoscopy Training for GI Trainees: The Impact of a 2-Day Introductory Training Course On Cognitive Knowledge. Gastrointestinal Endoscopy. AB312-AB312. 2007
- GI Endoscopy Training: Validation of a Computer-Based Endoscopy Simulator. Gastrointestinal Endoscopy. AB316-AB316. 2007
- Inhibition of acid secretion by a novel proton pump inhibitor (PPI). Gastroenterology. A486-A486. 2007
- S-tenatoprazole-na 30 Mg, 60 Mg and 90 Mg versus esomeprazole (Eso) 40 Mg in healthy male volunteers (Hmvs). Gastroenterology. A488-A489. 2007
- Baseline analysis of symptom spectrum in GORD: results from ReQuest (TM) database. Journal of Gastroenterology and Hepatology. A248-A248. 2006
- International GORD symptom thresholds based on the ReQuest (TM) questionnaire definition of symptom relief in clinical studies. Journal of Gastroenterology and Hepatology. A356-A356. 2006
- AGN 201904-Z (AGN), a Novel Enteric-Coated PPI, Produces Greater, More Prolonged Acid Suppression Than Esomeprazole (ESO) in Healthy Male Volunteers. American Journal of Gastroenterology. S92-S92. 2006
- Oral Rabeprazole 20 Mg Provides More Effective Acid Control Than IV Pantoprazole 40 Mg. American Journal of Gastroenterology. S80-S80. 2006
- Targeted esophageal biopsies: What you see is what you get (WYSIWYG) - Or not?. Gastroenterology. A161-A162. 2006
- Esomeprazole and pantoprazole: A comparison for maintenance treatment of healed erosive oesophagitis. Gut. A14-A14. 2005
- Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004. Canadian Journal of Gastroenterology and Hepatology. 15-35. 2005
- Management of adenocarcinoma risk: Discussion. Alimentary Pharmacology and Therapeutics, Supplement. 95-96. 2004
- PGI9 RESPONSIVENESS TO CHANGE AND ENGLISH LANGUAGE VALIDATION OF THE WPAI-GERD QUESTIONNAIRE-RESULTS FROM A CANADIAN STUDY. Value in Health. 349-349. 2004
- PGS6: THE COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES IN THE MANAGEMENT OF PATIENTS WITH UNINVESTIGATED DYSPEPSIA (UD): COMPARING THE CANDYS APPROACH TO EMPIRICAL ANTISECRETORY THERAPY AND PROMPT ENDOSCOPY. Value in Health. 246-247. 2003
- Magnet-tracing (MT) in the gastrointestinal (GI) tract: a new technique for non-invasive verification of nasogastric tube (NGT) placement. Gastroenterology. A24-A25. 2003
- Orocecal transit times (OCTT) in healthy subjects assessed by magnet-tracing (MT) and lactulose breath hydrogen test (LBHT). Gastroenterology. A426-A426. 2003
- The ROME II definition of dyspepsia does not exclude patients with gastroesophageal reflux disease (GERD) in primary care. Gastroenterology. A223-A224. 2003
- The prevalence of Barrett's esophagus in primary care patients with uninvestigated dyspepsia. Gastroenterology. A644-A644. 2003
- High dose intravenous proton pump inhibitors (IV PPI) decrease hospital mortality in selected patients with upper gastrointestinal bleeding. American Journal of Gastroenterology. S230-S230. 2002
- Predictors of treatment response and relapse for heartburn-dominant uninvestigated dyspepsia (HBDUD) in primary care practice (PCP): the CADET-HR study. American Journal of Gastroenterology. S36-S36. 2002
- Predictors of treatment response in patients with endoscopy-negative reflux disease (ENRD). American Journal of Gastroenterology. S12-S12. 2002
- Home-care parenteral nutrition (PN) is cost-saving: Economic analysis of a home PN (HPN) service in Ontario, Canada.. American Journal of Clinical Nutrition. 429S-429S. 2002
- Desirable impacts on acid reflux and gastric pH. European Journal of Gastroenterology and Hepatology. S50-S53. 2001
- Diagnostic significance, provocants and time-course of heartburn and regurgitation. European Journal of Gastroenterology and Hepatology. S21-S22. 2001
- Should acid reflux be abolished in patients with oesophageal columnar metaplasia?. European Journal of Gastroenterology and Hepatology. S38-S40. 2001
- Symptom status as a surrogate for absence of endoscopic oesophagitis. European Journal of Gastroenterology and Hepatology. S76-S78. 2001
- The role of Helicobacter pylori (H.p.) infection in predicting endoscopic abnormalities in 1040 patients with uninvestigated dyspepsia (UD). The CADET-PE study. Gut. A96-A96. 2001
- Gastroesophageal reflux disease (GERD) symptoms (GS) in 5 European countries: a common and poorly understood condition. Gastroenterology. A427-A427. 2001
- Intravenous acid suppression - Appropriateness of use in a tertiary care setting. Gastroenterology. A730-A730. 2001
- Is prompt endoscopy necessary in uninvestigated dyspeptics? Prevalence of upper gastrointestinal abnormalities - The CADET-PE study.. Gastroenterology. A50-A51. 2001
- Significant and rapid HRQoL improvement correlates with symptom relief in GERD patients using pantoprazole (Panto) as compared to nizatidine (Niza).. Gastroenterology. A433-A433. 2001
- Session 4: Long-term medical management. European Journal of Gastroenterology and Hepatology. 2001
- Association of family history of gastric cancer, intestinal metaplasia and high gastric juice ammonia in patients with Helicobacter pylori infection. Gastroenterology. A1216-A1216. 2000
- Can symptoms be used to diagnose lactose intolerance?. Gastroenterology. A373-A373. 2000
- Esomeprazole 40mg and 20mg is efficacious in the long-term management of patients with endoscopy-negative gerd: A placebo-controlled trial of on-demand therapy for 6 months. Gastroenterology. A658-A658. 2000
- The test and treat strategy for dyspepsia: Cost-effectiveness of the order of eradication strategies. Gastroenterology. A207-A207. 2000
- “Step-up” or step-down? A 4-week comparison of pantoprazole, 40 mg daily and nizatidine, 150 mg bid in symptomatic gastroesophageal reflux disease (GERD). Gastroenterology. A1212-A1212. 2000
- C-13-urea breath test or H-pylori serology for the initial evaluation of young patients with ulcer-like dyspepsia: A decision analysis. Gastroenterology. A78-A78. 1999
- Cost-effectiveness of acid suppression versus misoprostol in the prevention of non-steroidal antliinflammatory drug (NSAID)-induced ulcers. Gastroenterology. A72-A72. 1999
- Gastroesophageal reflux disease (GERD): Is the "acid test" sufficient?. Gastroenterology. A114-A114. 1999
- Two-lumen tubing is required for accurate barostat studies. Gastroenterology. A846-A846. 1998
- A novel approach to assess brain processing of esophageal sensation using cognitive evoked P300-potentials. Gut. A82-A82. 1997
- Apparent increase in acid output during omeprazole (OME) after cure of H-pylori infection (HpI).. Gastroenterology. A70-A70. 1997
- Barostat-controlled, rectal distention modifies heart rate variability in healthy subjects.. Gastroenterology. A693-A693. 1997
- A low resting vagal tone predicts response to acid perfusion in patients with esophageal symptoms.. Gastroenterology. A762-A762. 1996
- Autonomic response to esophageal acid perfusion in patients with esophageal symptoms.. Gastroenterology. A762-A762. 1996
- Barostat-controlled esophageal balloon distension produces a pressure-dependent heart rate decrease in healthy subjects. Gastroenterology. A624-A624. 1996
- Differences in acid secretory response and serology in H-pylori positive patients after successful and failed triple therapy. Gastroenterology. A142-A142. 1996
- H-pylori related increase in omeprazole (OME) effect is associated with ammonia production.. Gastroenterology. A64-A64. 1996
- Intragastric pH and omeprazole (OME): Role of Helicobacter pylori (HP) and HP-associated gastritis.. Gastroenterology. A285-A285. 1996
- Low pressure, unperceived, barostat-controlled esophageal distension decreases heart rate in healthy subjects. Gastroenterology. A625-A625. 1996
- Production of volatile amines by Helicobacter pylori (HP) is not relevant in vivo.. Gastroenterology. A285-A285. 1996
- A PREDICTIVE MODEL OF MUCOSAL DAMAGE IN GERD USING AREA-UNDER-THE-CURVE ESTIMATION OF HYDROGEN-ION ACTIVITY (AUC H+). Gastroenterology. A55-A55. 1995
- Effect of curing Helicobacter pylori (HP) infection on intragastric pH during omeprazole treatment. Gastroenterology. A250-A250. 1995
- PROTRACTED GASTRIC-ACID SECRETION IN HELICOBACTER-PYLORI POSITIVE DU PATIENTS FOLLOWING ERADICATION. Gastroenterology. A122-A122. 1995
- When should the position of Z-line and hiatus be measured during upper gastrointestinal endoscopy (UGE)?. Gastroenterology. A84-A84. 1995
- Methods to study gastric emptying. Digestive Diseases and Sciences. 130S-132S. 1994
- LANSOPRAZOLE AND OMEPRAZOLE, AT THERAPEUTIC DOSES, PRODUCE EQUIVALENT RISES IN GASTRIC PH IN HELICOBACTER-PYLORI (HP) POSITIVE SUBJECTS. Gastroenterology. A205-A205. 1994
- DOES THE TREATMENT AND HEALING OF ESOPHAGITIS INFLUENCE THE PATHOPHYSIOLOGY OF REFLUX DISEASE. International Congress Series. 470-480. 1994
- THE MUSE SYSTEM. International Congress Series. 313-318. 1994
- An amperometric enzyme electrode for bile acids. Analytica Chimica Acta. 655-661. 1993
- A COMPARISON OF 2 METHODS FOR THE ENDOSCOPIC ASSESSMENT OF REFLUX ESOPHAGITIS (RO). Gastroenterology. A35-A35. 1993
- DOES RAPID HEALING OF PEPTIC-ULCER PREDISPOSE TO EARLIER RELAPSE. Gastroenterology. A35-A35. 1993
- DUODENOGASTRIC REFLUX (DGR) MONITORING - IS GASTRIC PH-METRY ADEQUATE. Gastroenterology. A218-A218. 1993
- INFLUENCE OF PERSONALITY-CHARACTERISTICS (PC) AND STRESS (S) ON DUODENAL-ULCER (DU) RECURRENCE (R). Gastroenterology. A73-A73. 1993
- LUMINAL DISTENSION, MOTILITY PATTERNS AND LUMINAL TRANSPORT IN ISOLATED ARTERIALLY PERFUSED RAT ILEUM. Gastroenterology. A476-A476. 1993
- MECHANICAL CORRELATES OF INTESTINAL FLUID-FLOW IN AN ISOLATED ARTERIALLY PERFUSED RAT ILEUM. Gastroenterology. A476-A476. 1993
- Multichannel ISFET catheter for temporal and spatial pH variation studies in the stomach over 24 hours. Sensors and Actuators, B: Chemical. 332-335. 1992
- Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical?. Hepato-Gastroenterology: current medical and surgical trends. 3-13. 1992
- THE ROLE OF THE ENS IN SMALL INTESTINAL MOTILITY - STUDIES IN AN ISOLATED ARTERIALLY-PERFUSED LOOP INVITRO. European Journal of Neuroscience. 147-147. 1992
- DUODENAL ULCERATION DURING MAINTENANCE RANITIDINE THERAPY - SILENT AND DEADLY. Gut. A584-A584. 1991
- MISOPROSTOL DOES NOT PREVENT THE GASTRODUODENAL MUCOSAL EFFECTS OF THE NONSTEROIDAL ANTIINFLAMMATORY DRUG, DICLOFENAC. Gut. A571-A571. 1991
- PERSISTENT GASTRITIS AFTER RANITIDINE OR ANTACID THERAPY PREDICTS RELAPSE OF DUODENAL ULCERATION. Gut. A595-A595. 1991
- Circadian rhythms of gastric acidity in healthy man. Hepato-Gastroenterology: current medical and surgical trends. 262-263. 1990
- 24 HOUR PATTERN OF ESOPHAGEAL MOTILITY. Gut. A1491-A1491. 1989
- COMPUTER ANALYZED AMBULATORY MANOMETRY OF ESOPHAGEAL MOTILITY. Gut. A1491-A1492. 1989
- FULL DOSE H2 RECEPTOR ANTAGONIST PROPHYLAXIS DOES NOT PREVENT RELAPSE OF REFLUX ESOPHAGITIS. Gut. A1494-A1494. 1989
- CHRONIC ENTEROGASTRIC REFLUX (EGR) INCREASES THE GASTROTOXICITY OF AN ACUTE BILE-ACID CHALLENGE IN THE RAT. Gut. A1477-A1478. 1988
- THE RELATIVE GASTROTOXICITY OF DUODENAL JUICE COMPONENTS - ACUTE STUDIES IN THE RAT. Gastroenterology. A13-A13. 1988
- IS CONTINUOUS AMBULATORY MONITORING OF DUODENOGASTRIC REFLUX FEASIBLE - INVITRO ASSESSMENT OF AN ENZYMATIC AMPEROMETRIC BILE-ACID ELECTRODE. Gut. A1395-A1395. 1987
- THE DIFFERING GASTROTOXICITY OF VARIOUS BILE-ACIDS - STUDIES WITH AN EXVIVO RAT GASTRIC CHAMBER MODEL. Clinical Science. P45-P45. 1987
- ARE BILE-ACIDS GASTROTOXIC IN DUODENOGASTRIC REFLUX - DOSE-RESPONSE AND STRUCTURE ACTIVITY STUDIES USING AN EXVIVO RAT GASTRIC CHAMBER MODEL. Gut. 1235-1235. 1986
journal articles
- Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?. Journal of the Canadian Association of Gastroenterology. 7:312-318. 2024
- Risk of fibromyalgia following antibiotic prescriptions: A population‐based case–control study. European Journal of Pain. 28:1008-1017. 2024
- Enteral nutrition on discharge from intensive care and 30-day unplanned readmission: An exploratory, retrospective study of association. Clinical Nutrition ESPEN. 61:15-21. 2024
- The Canadian Association of Gastroenterology’s New Climate Change Committee. Journal of the Canadian Association of Gastroenterology. 7:135-136. 2024
- Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review. BMJ Open. 14:e079750-e079750. 2024
- Nutrition Assessment and Management in Celiac Disease. Gastroenterology. 167:116-131.e1. 2024
- Symptom Profile, Proton Pump Inhibitor Therapy, and Diagnostic Testing in Patients With Persistent Reflux-Like Symptoms: Results From a Population-Based Survey. Foregut. 4:32-39. 2024
- Comment on Chao, H.-C. Zinc Deficiency and Therapeutic Value of Zinc Supplementation in Pediatric Gastrointestinal Diseases. Nutrients 2023, 15, 4093. Nutrients. 16:134-134. 2023
- Editorial: On‐demand vonoprazan forNERD– when should it be ‘demanded’? Authors' reply. Alimentary Pharmacology and Therapeutics. 58:1231-1231. 2023
- Randomised clinical trial: Efficacy and safety of on‐demand vonoprazan versus placebo for non‐erosive reflux disease. Alimentary Pharmacology and Therapeutics. 58:1016-1027. 2023
- Ethnic differences in physical and mental multimorbidity in working age adults with a history of depression and/or anxiety. Psychological Medicine. 53:6212-6222. 2023
- Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition. 47:878-887. 2023
- The Geras virtual frailty rehabilitation program to build resilience in older adults with frailty during COVID-19: a randomized feasibility trial. Pilot and Feasibility Studies. 9:124. 2023
- Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease.. Gastroenterology and Hepatology. 19:295-298. 2023
- The social life of risk probabilities in medicine. Social Science and Medicine. 323:115811-115811. 2023
- Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity. Nutrients. 15:1475-1475. 2023
- NutriSup-PPN: A pilot randomized control trial of oral nutritional supplementation (ONS) and peripheral parenteral nutrition (PPN) in canadian, malnourished, hospitalized patients. Clinical Nutrition ESPEN. 53:107-112. 2023
- The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development. Journal of Clinical Epidemiology. 154:197-203. 2023
- Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients. Gastroenterology. 164:228-240. 2023
- Head-to-Head Diagnostic Test Accuracy Meta-analysis of Colonoscopy and Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia. Middle East Journal of Digestive Diseases. 15:5-11. 2023
- Physical multimorbidity, depressive symptoms, and social participation in adults over 50 years of age: findings from the English Longitudinal Study of Ageing. Aging & Mental Health. 27:43-53. 2023
- Micronutrient deficiencies are frequent in adult patients with and without celiac disease on a gluten-free diet, regardless of duration and adherence to the diet. Nutrition. 103-104:111809-111809. 2022
- Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-analysis. Middle East Journal of Digestive Diseases. 14:382-395. 2022
- Knowledge gaps in the management of refractory reflux‐like symptoms: Healthcare provider survey. Neurogastroenterology and Motility. 34:e14387. 2022
- Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 56:794-797. 2022
- Letter to the Editor: Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn’s Disease Patients. Inflammatory Bowel Diseases. 28:e120-e120. 2022
- Rise and fall of the (social) group. Social Studies of Science. 52:618-634. 2022
- Psychometric origins of depression. History of the Human Sciences. 35:127-143. 2022
- Rio de Janeiro Global Consensus on Landmarks, Definitions, and Classifications in Barrett’s Esophagus: World Endoscopy Organization Delphi Study. Gastroenterology. 163:84-96.e2. 2022
- Diarrhea during critical illness: a multicenter cohort study. Intensive Care Medicine. 48:570-579. 2022
- Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist. ACP journal club. 175:735-739. 2022
- Prospective associations between depression and risk of hospitalisation for infection: Findings from the UK Biobank. Brain, Behavior, and Immunity. 102:292-298. 2022
- Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021. Current Oncology. 29:1723-1743. 2022
- Home parenteral nutrition in older vs younger patients: Clinical characteristics and outcomes. Journal of Parenteral and Enteral Nutrition. 46:348-356. 2022
- Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 5:12-17. 2022
- The complexities of approaching nutrition in inflammatory bowel disease: current recommendations and future directions. Nutrition Reviews. 80:215-229. 2022
- A Real-Time Endoscope Motion Tracker. IEEE Journal of Translational Engineering in Health and Medicine. 10:1-9. 2022
- Prior antibiotics and risk of subsequent Herpes zoster: A population-based case control study. PLoS ONE. 17:e0276807-e0276807. 2022
- Are some feasibility studies more feasible than others? A review of the outcomes of feasibility studies on the ISRCTN registry. Pilot and Feasibility Studies. 7:195. 2021
- Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes. BMC Health Services Research. 21:172. 2021
- Depressive symptoms during early adulthood and the development of physical multimorbidity in the UK: an observational cohort study. The Lancet Healthy Longevity. 2:e801-e810. 2021
- Guideline-based quality assurance: a conceptual framework for the definition of key elements. BMC Health Services Research. 21:173. 2021
- Psychological interventions for reducing anxiety in patients undergoing first-time colonoscopy: a pilot and feasibility study. European Journal of Gastroenterology and Hepatology. 33:e634-e641. 2021
- Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. Clinical Gastroenterology and Hepatology. 19:2343-2352.e8. 2021
- Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Non-Recyclable Waste. Gastroenterology. 161:1354-1360. 2021
- Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Nonrecyclable Waste. Journal of Clinical Gastroenterology. 55:823-829. 2021
- Uniting the global gastroenterology community to meet the challenge of climate change and non-recyclable waste. Gut. 70:2025-2029. 2021
- Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial. Journal of the Canadian Association of Gastroenterology. 4:214-221. 2021
- Associations between physical multimorbidity patterns and common mental health disorders in middle-aged adults: A prospective analysis using data from the UK Biobank. The Lancet Regional Health - Europe. 8:100149-100149. 2021
- The COVID‐19 pandemic and cause of death. Sociology of Health and Illness. 43:1614-1626. 2021
- Convolutional neural networks for medical image analysis: State-of-the-art, comparisons, improvement and perspectives. Neurocomputing. 444:92-110. 2021
- Home parenteral nutrition patients on mixed oil lipid emulsion have a higher rate of hospitalizations compare to those on soybean oil– a prospective 2-year cohort study. Clinical Nutrition. 40:4616-4623. 2021
- Survival of Patients With Short‐Bowel Syndrome on Home Parenteral Nutrition: A Prospective Cohort Study. Journal of Parenteral and Enteral Nutrition. 45:1083-1088. 2021
- Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey. Inflammatory Bowel Diseases. 27:836-847. 2021
- Comment on: Influence of prior antibiotic use on risk of rheumatoid arthritis: case–control study in general practice. Reply. Rheumatology. 60:e150-e150. 2021
- Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis. Gut Microbes. 13:1-18. 2021
- Patients’ Experiences and Challenges in Living with Inflammatory Bowel Disease: A Qualitative Approach. Clinical and Experimental Gastroenterology. Volume 14:123-131. 2021
- WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. Journal of Clinical Gastroenterology. 55:1-11. 2021
- Approaches of integrating the development of guidelines and quality indicators: a systematic review. BMC Health Services Research. 20:875. 2020
- Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respiratory Research. 21:3. 2020
- Personal Protective Equipment for Endoscopy in Low-Resource Settings During the COVID-19 Pandemic. Journal of Clinical Gastroenterology. 54:833-840. 2020
- Lean implementation within healthcare: imaging as fertile ground. Journal of Health Organization and Management. 34:869-884. 2020
- An Electronic Clinical Decision-Making Tool for Patients with Suspected Colorectal Cancer—Preliminary Evaluation in Patients Presenting with Rectal Bleeding. Journal of the Canadian Association of Gastroenterology. 3:204-209. 2020
- Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, Supplement. 55:800-805. 2020
- Association Between Age and Complications After Outpatient Colonoscopy. JAMA network open. 3:e208958-e208958. 2020
- Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series. Clinical Nutrition. 39:1774-1777. 2020
- Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice. Rheumatology. 59:1281-1287. 2020
- Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 3:98-99. 2020
- The association between colorectal cancer and prior antibiotic prescriptions: case control study. British Journal of Cancer. 122:912-917. 2020
- Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 3:e1-e9. 2020
- Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD. Frontiers in Pediatrics. 8:620189. 2020
- Optical Biopsy of the Upper GI Tract Using Fluorescence Lifetime and Spectra. Frontiers in Physiology. 11:339. 2020
- Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom. PLoS ONE. 15:e0230674-e0230674. 2020
- Anxiety, Depression and Quality of Life Improve After One Month and Three Months of Home Parenteral Nutrition: A Pilot Study in a Canadian Population. Journal of the Canadian Association of Gastroenterology. 2:178-185. 2019
- Ethnic differences in psychosis—Lay epidemiology explanations. Health Expectations. 22:965-973. 2019
- Obesity and Weight Change in Two United Kingdom Male Prisons. Journal of Correctional Health Care. 25:328-337. 2019
- Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop. Health Technology Assessment. 23:1-88. 2019
- Prisons and Embodiment: Self-Management Strategies of an Incarcerated Population. Journal of Correctional Health Care. 25:338-350. 2019
- Diagnosis: From classification to prediction. Social Science and Medicine. 237:112444-112444. 2019
- Egyptian recommendations for management of Helicobacter pylori infection: 2018 report. Arab Journal of Gastroenterology. 20:175-179. 2019
- Variations in practice patterns for adult cancer patients on home parenteral nutrition in Canada. Nutrition. 65:27-32. 2019
- Placental Membrane Provides Improved Healing Efficacy and Lower Cost Versus a Tissue-Engineered Human Skin in the Treatment of Diabetic Foot Ulcerations. Plastic and Reconstructive Surgery - Global Open. 7:e2371-e2371. 2019
- Proton pump inhibitors and gastric cancer: association is not causation. Gut. 68:1529.2-1530. 2019
- Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology. 2:132-140. 2019
- Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery. 58:S1-S109.e33. 2019
- Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis. Clinical Gastroenterology and Hepatology. 17:1477-1488.e10. 2019
- Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study. BMJ Open. 9:e028237-e028237. 2019
- Multi‐centre ethics and research governance review can impede non‐interventional clinical research. Internal Medicine Journal. 49:722-728. 2019
- Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation. Annals of the Rheumatic Diseases. 78:688-695. 2019
- An Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett’s Esophagus–Related Neoplasia. Gastroenterology. 156:1299-1308.e3. 2019
- The social life of data points: Antecedents of digital technologies. Social Studies of Science. 49:102-117. 2019
- Associations Between Colonic Motor Patterns and Autonomic Nervous System Activity Assessed by High-Resolution Manometry and Concurrent Heart Rate Variability. Frontiers in Neuroscience. 13:1447. 2019
- Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication. Journal of the Canadian Association of Gastroenterology. 1:155-158. 2018
- DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. Trials. 19:606. 2018
- Getting fit for hip and knee replacement: a protocol for the Fit-Joints pilot randomized controlled trial of a multi-modal intervention in frail patients with osteoarthritis. Pilot and Feasibility Studies. 4:127. 2018
- DELTA² guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. The BMJ. 363:k3750-k3750. 2018
- A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups. Gastroenterology Nursing. 41:427-435. 2018
- Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn’s disease. American Journal of Physiology - Gastrointestinal and Liver Physiology. 315:G420-G431. 2018
- Systematic review into obesity and weight gain within male prisons. Obesity Research and Clinical Practice. 12:327-335. 2018
- Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry. Frontiers in Physiology. 9:1248. 2018
- Communicating Gastrointestinal Symptoms: The Patient’s Challenge. Critical Reviews in Biomedical Engineering. 46:83-92. 2018
- Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology. 153:395-409.e3. 2017
- Corrigendum to “Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement”. Canadian Journal of Gastroenterology and Hepatology. 2017:1-1. 2017
- Changes in Home Parenteral Nutrition Practice Based on the Canadian Home Parenteral Nutrition Patient Registry. Journal of Parenteral and Enteral Nutrition. 41:830-836. 2017
- World Gastroenterology Organisation Global Guidelines. Journal of Clinical Gastroenterology. 51:467-478. 2017
- Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. Gastroenterology. 152:497-514. 2017
- Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents. Canadian Journal of Gastroenterology and Hepatology. 2017:1-11. 2017
- Non-prescription proton-pump inhibitors for self-treating frequent heartburn: the role of the Canadian pharmacist. Pharmacy Practice. 14:868-868. 2016
- Canadian Association of Gastroenterology: Strategic Plan 2016–2020. Canadian Journal of Gastroenterology and Hepatology. 2016:1-3. 2016
- Deep Learning in Gastrointestinal Endoscopy. Critical Reviews in Biomedical Engineering. 44:493-504. 2016
- Malnutrition Matters in Canadian Hospitalized Patients. Nutrition in Clinical Practice. 30:709-713. 2015
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 149:102-109.e6. 2015
- Management of reflux esophagitis: does the choice of proton pump inhibitor matter?. International Journal of Clinical Practice. 69:796-801. 2015
- Epidemiology and Risk Factors for Bloodstream Infections in a Home Parenteral Nutrition Program. Journal of Parenteral and Enteral Nutrition. 39:147-153. 2015
- Response to Atreja et al.. American Journal of Gastroenterology. 110:346-347. 2015
- WDHD May 29, 2015. Heartburn: A global perspective: Message from the Chair. South African Gastroenterology Review. 13:32. 2015
- Development and Validation of a Symptom-Based Activity Index for Adults With Eosinophilic Esophagitis. Gastroenterology. 147:1255-1266.e21. 2014
- Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology. 109:811-819. 2014
- Adherence to Guidelines: A National Audit of the Management of Acute upper Gastrointestinal Bleeding. The REASON Registry. Canadian Journal of Gastroenterology and Hepatology. 28:495-501. 2014
- GERD and Obesity: Is the Autonomic Nervous System the Missing Link?. Critical Reviews in Biomedical Engineering. 42:17-24. 2014
- Quality Indicators for Colonoscopy: The Road Forward. Canadian Journal of Gastroenterology and Hepatology. 28:242-242. 2014
- Gamma-amino butyric acid (GABA) receptor agonists for gastroesophageal reflux disease (GERD). Clinical Respiratory Journal. 2013. 2013
- Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures: multidisciplinary task force report.. Canadian Family Physician. 59:1055-e448. 2013
- What is the role of endoscopy and oesophageal biopsies in the management of GERD?. Best Practice and Research in Clinical Gastroenterology. 27:373-385. 2013
- Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux disease. Cochrane Database of Systematic Reviews. 2013. 2013
- The impact of intensifying acid suppression on sleep disturbance related to gastro‐oesophageal reflux disease in primary care. Alimentary Pharmacology and Therapeutics. 37:730-737. 2013
- Novel Pharmaceutical Approaches to Reflux Disease. Gastroenterology Clinics of North America. 42:93-117. 2013
- Effectiveness of disseminating consensus management recommendations for ulcer bleeding: a cluster randomized trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 185:E156-E166. 2013
- Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes. Inflammatory Bowel Diseases. 19:332-341. 2013
- Patient-Identified Quality Indicators for Colonoscopy Services. Canadian Journal of Gastroenterology and Hepatology. 27:25-32. 2013
- Summary of Guidelines for Infection Prevention and Control for Flexible Gastrointestinal Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 27:347-350. 2013
- The 2012 Sage Wait Times Program: Survey of Access to Gastroenterology in Canada. Canadian Journal of Gastroenterology and Hepatology. 27:83-89. 2013
- Prevalence of Helicobacter pylori infection in children in the Bahamas.. West Indian Medical Journal. 61:698-702. 2012
- Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process. Gastroenterology. 143:336-346. 2012
- Canadian Home Parenteral Nutrition (HPN) Registry. Journal of Parenteral and Enteral Nutrition. 36:407-414. 2012
- The Canadian Home Total Parenteral Nutrition (HTPN) Registry. Journal of Parenteral and Enteral Nutrition. 36:415-420. 2012
- Improving serological test ordering patterns for the diagnosis of celiac disease through clinical laboratory audit of practice. Clinical Biochemistry. 45:455-459. 2012
- A Survey of the Practice of After-Hours and Emergency Endoscopy in Canada. Canadian Journal of Gastroenterology and Hepatology. 26:871-876. 2012
- Canadian Association of Gastroenterology Consensus Guidelines on Safety and Quality Indicators in Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 26:17-31. 2012
- Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement. Canadian Journal of Gastroenterology and Hepatology. 26:819-829. 2012
- Indicators of Safety Compromise in Gastrointestinal Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 26:71-78. 2012
- Predictors of a Variceal Source among Patients Presenting with Upper Gastrointestinal Bleeding. Canadian Journal of Gastroenterology and Hepatology. 26:187-192. 2012
- Report on the Expert Forum on using Information Technology to Facilitate Uptake and Impact of Colorectal Cancer Screening Guidelines. Canadian Journal of Gastroenterology and Hepatology. 26:902-904. 2012
- Safety of Esophagogastroduodenoscopy within 30 Days of Myocardial Infarction: A Retrospective Cohort Study from a Canadian Tertiary Centre. Canadian Journal of Gastroenterology and Hepatology. 26:151-154. 2012
- New Pharmacologic Approaches in Gastroesophageal Reflux Disease. Thoracic Surgery Clinics. 21:557-574. 2011
- Barrett's esophagus: histology and immunohistology. Annals of the New York Academy of Sciences. 1232:76-92. 2011
- Barrett's esophagus: proton pump inhibitors and chemoprevention II. Annals of the New York Academy of Sciences. 1232:114-139. 2011
- A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surgical Endoscopy. 25:2547-2554. 2011
- Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation. Value in Health. 14:263-273. 2011
- A Literature Review of Quality in Lower Gastrointestinal Endoscopy from the Patient Perspective. Canadian Journal of Gastroenterology and Hepatology. 25:681-685. 2011
- Point-of-Care, Peer-Comparator Colonoscopy Practice Audit: The Canadian Association of Gastroenterology Quality Program – Endoscopy. Canadian Journal of Gastroenterology and Hepatology. 25:13-20. 2011
- Testing for Gluten-Related Disorders in Clinical Practice: The Role of Serology in Managing the Spectrum of Gluten Sensitivity. Canadian Journal of Gastroenterology and Hepatology. 25:193-197. 2011
- Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable. Muscle and Nerve. 42:853-855. 2010
- The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial. American Journal of Gastroenterology. 105:2341-2346. 2010
- New Pharmacologic Approaches in Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America. 39:393-418. 2010
- Measuring Quality of Care in Patients With Nonvariceal Upper Gastrointestinal Hemorrhage: Development of an Explicit Quality Indicator Set. American Journal of Gastroenterology. 105:1710-1718. 2010
- The pharmacodynamics and pharmacokinetics of S‐tenatoprazole‐Na 30 mg, 60 mg and 90 mg vs. esomeprazole 40 mg in healthy male subjects. Alimentary Pharmacology and Therapeutics. 31:648-657. 2010
- Latin American Consensus on Gastroesophageal Reflux Disease: An Update on Therapy. Gastroenterologia y Hepatologia. 33:135-147. 2010
- A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care. Canadian Journal of Gastroenterology and Hepatology. 24:489-498. 2010
- Between Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten Sensitivity. American Journal of Gastroenterology. 104:1587-1594. 2009
- Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study. Alimentary Pharmacology and Therapeutics. 29:1165-1171. 2009
- Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis – results from the EXPO study. Alimentary Pharmacology and Therapeutics. 29:959-966. 2009
- Non-Variceal Upper GI Bleeding in Patients Already Hospitalized for Another Condition. American Journal of Gastroenterology. 104:330-339. 2009
- Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. Journal of Clinical Epidemiology. 62:102-110. 2009
- Response:. Gastrointestinal Endoscopy. 68:810-811. 2008
- Systematic review: persistence and severity in gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 28:841-853. 2008
- Should patients with Barrett's oesophagus be kept under surveillance? The case for. Best Practice and Research in Clinical Gastroenterology. 22:721-739. 2008
- Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904‐Z. Alimentary Pharmacology and Therapeutics. 28:187-199. 2008
- EUS: a meta-analysis of test performance in suspected choledocholithiasis. Gastrointestinal Endoscopy. 67:235-244. 2008
- A Critical Assessment of the Current Status of Non-Erosive Reflux Disease. Digestion. 78:46-54. 2008
- Access to Specialist Gastroenterology Care in Canada: Comparison of Wait Times and Consensus Targets. Canadian Journal of Gastroenterology and Hepatology. 22:161-167. 2008
- Access to Specialist Gastroenterology Care in Canada: The Practice Audit in Gastroenterology (PAGE) Wait Times Program. Canadian Journal of Gastroenterology and Hepatology. 22:155-160. 2008
- Canadian Credentialing Guidelines for Colonoscopy. Canadian Journal of Gastroenterology and Hepatology. 22:17-22. 2008
- Canadian Credentialing Guidelines for Endoscopic Retrograde Cholangiopancreatography. Canadian Journal of Gastroenterology and Hepatology. 22:547-551. 2008
- Canadian Credentialing Guidelines for Esophagogastroduodenoscopy. Canadian Journal of Gastroenterology and Hepatology. 22:349-354. 2008
- Canadian Credentialing Guidelines for Flexible Sigmoidoscopy. Canadian Journal of Gastroenterology and Hepatology. 22:115-119. 2008
- Low Prevalence ofHelicobacter PyloriInfection in Canadian Children: A Cross-Sectional Analysis. Canadian Journal of Gastroenterology and Hepatology. 22:485-489. 2008
- Die Montreal-Definition und -Klassifikation der gastroösophagealen Refluxkrankheit: Ein globales evidenzbasiertes Konsensus-Papier. Zeitschrift für Gastroenterologie. 45:1125-1140. 2007
- Evaluation of densitometric bone–muscle relationships in Crohn's disease. Bone. 40:1610-1614. 2007
- Juvenile onset of Crohn's disease: A risk factor for reduced lumbar bone mass in premenopausal women. Bone. 40:1290-1293. 2007
- Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire. Alimentary Pharmacology and Therapeutics. 25:1087-1097. 2007
- GERD Evaluation. Journal of Clinical Gastroenterology. 41:237-241. 2007
- Simple Clinical Predictors May Obviate Urgent Endoscopy in Selected Patients With Nonvariceal Upper Gastrointestinal Tract Bleeding. JAMA Internal Medicine. 167:265-265. 2007
- Canadian Credentialing Guidelines for Endoscopic Privileges: An Overview. Canadian Journal of Gastroenterology and Hepatology. 21:797-801. 2007
- Cancer Care Ontario Colonoscopy Standards: Standards and Evidentiary Base. Canadian Journal of Gastroenterology and Hepatology. 21:5D-24D. 2007
- Clinical Onset of Celiac Disease after an Episode ofCampylobacter jejuniEnteritis. Canadian Journal of Gastroenterology and Hepatology. 21:453-455. 2007
- Determination of ReQuest<sup>TM</sup>-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies. Digestion. 75:55-61. 2007
- Endoscopy and Quality Assurance – It is Here!. Canadian Journal of Gastroenterology and Hepatology. 21:255-256. 2007
- Evaluation of GERD Symptoms during Therapy. Digestion. 75:41-47. 2007
- Evaluation of GERD Symptoms during Therapy. Digestion. 75:32-40. 2007
- Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients. Canadian Journal of Gastroenterology and Hepatology. 21:637-642. 2007
- International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease. Digestion. 75:48-54. 2007
- Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary Pharmacology and Therapeutics. 25:185-196. 2007
- Photodynamic Therapy for Barrett’s Esophagus with High-Grade Dysplasia: A Cost-Effectiveness Analysis. Canadian Journal of Gastroenterology and Hepatology. 21:217-222. 2007
- Systematic Review: Do We Need a New Gastro-Oesophageal Reflux Disease Questionnaire?. Digestion. 75:3-16. 2007
- The Construction of a New Evaluative GERD Questionnaire – Methods and State of the Art. Digestion. 75:17-24. 2007
- The Effect of Sham Feeding on Neurocardiac Regulation in Healthy Human Volunteers. Canadian Journal of Gastroenterology and Hepatology. 21:721-726. 2007
- The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD). PharmacoEconomics (Auckland). 25:385-396. 2007
- A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Versus Proton Pump Inhibitors for Treatment of Patients With Chronic Gastroesophageal Reflux Disease: One-Year Follow-Up. Surgical Innovation. 13:238-249. 2006
- C-13 urea breath test for Helicobacter pylori: Determination of the optimal cut-off point in a Canadian community population. Canadian Journal of Gastroenterology and Hepatology. 20:770-774. 2006
- C-13 urea breath test for Helicobacter pylori: Evaluation of 10-minute breath collection. Canadian Journal of Gastroenterology and Hepatology. 20:775-778. 2006
- The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria. Gastroenterology. 131:1392-1399. 2006
- Efficacy of Anal Fistula Plug in Closure of Crohn's Anorectal Fistulas. Diseases of the Colon and Rectum. 49:1569-1573. 2006
- Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia: The Randomized, Placebo-Controlled “ENTER” Trial. American Journal of Gastroenterology. 101:2096-2106. 2006
- Predictors of treatment response in patients with non‐erosive reflux disease. Alimentary Pharmacology and Therapeutics. 24:371-376. 2006
- An evidence-based, Latin-American consensus on gastro-oesophageal reflux disease. European Journal of Gastroenterology and Hepatology. 18:349-368. 2006
- Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study. Current Medical Research and Opinion. 22:657-662. 2006
- The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Alimentary Pharmacology and Therapeutics. 23:595-599. 2006
- Errata. Alimentary Pharmacology and Therapeutics. 23:449-449. 2006
- Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.(vol 22, pg 803, 2005). Alimentary Pharmacology and Therapeutics. 23:449-449. 2006
- Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Alimentary Pharmacology and Therapeutics. 23:521-529. 2006
- Validation of a symptom diary for patients with gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 23:531-541. 2006
- ¹³C Urea Breath Test for Helicobacter pylori: Determination of the Optimal Cut-Off Point in a Canadian Community Population. Canadian Journal of Gastroenterology. 20:770-774. 2006
- ¹³C Urea Breath Test forHelicobacter pylori: Evaluation of 10-minute Breath Collection. Canadian Journal of Gastroenterology. 20:775-778. 2006
- Practice Audit in Gastroenterology (Page) Program: A Novel Approach to Continuing Professional Development. Canadian Journal of Gastroenterology and Hepatology. 20:405-410. 2006
- Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting. World Journal of Gastroenterology. 12:7779-7779. 2006
- Gastroesophageal reflux disease. Current Opinion in Pharmacology. 5:589-595. 2005
- The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterology. 5:23. 2005
- Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study¹. Alimentary Pharmacology and Therapeutics. 22:803-811. 2005
- Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers. American Journal of Gastroenterology. 100:1949-1956. 2005
- A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study. American Journal of Gastroenterology. 100:1477-1488. 2005
- Economic Analysis of Home vs Hospital‐Based Parenteral Nutrition in Ontario, Canada. Journal of Parenteral and Enteral Nutrition. 29:266-269. 2005
- Noninvasive Verification of Nasogastric Tube Placement Using a Magnet‐Tracking System: A Pilot Study in Healthy Subjects. Journal of Parenteral and Enteral Nutrition. 29:305-310. 2005
- Heartburn‐dominant, uninvestigated dyspepsia: a comparison of ‘PPI‐start’ and ‘H₂‐RA‐start’ management strategies in primary care – the CADET‐HR Study. Alimentary Pharmacology and Therapeutics. 21:1189-1202. 2005
- A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Alimentary Pharmacology and Therapeutics. 21:739-746. 2005
- A Sampling of Canadian Practice in Managing Nonvariceal Upper Gastrointestinal Bleeding before Recent Guideline Publication: Is there Room for Improvement?. Canadian Journal of Gastroenterology and Hepatology. 19:487-495. 2005
- Determination of ReQuest™-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies. Digestion. 71:145-151. 2005
- Evidence-Based Recommendations for Short- and Long-Term Management of Uninvestigated Dyspepsia in Primary Care: An Update of the Canadian Dyspepsia Working Group (CanDys) Clinical Management Tool. Canadian Journal of Gastroenterology and Hepatology. 19:285-303. 2005
- Intravenous proton pump inhibitor therapy: a rationale for use.. Reviews in Gastroenterological Disorders. 5 Suppl 2:S18-S30. 2005
- Reflux Questionnaire (ReQuest™). Digestion. 71:173-173. 2005
- Reply. Digestion. 71:174-175. 2005
- The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole.. Health and Quality of Life Outcomes. 3:4-4. 2005
- Validation of a Short Questionnaire in English and French for Use in Patients with Persistent Upper Gastrointestinal Symptoms Despite Proton Pump Inhibitor Therapy: The Pass (Proton Pump Inhibitor Acid Suppression Symptom) Test. Canadian Journal of Gastroenterology and Hepatology. 19:350-358. 2005
- A Randomized Multicenter Trial to Evaluate Simple Utility Elicitation Techniques in Patients With Gastroesophageal Reflux Disease. Medical Care. 42:1132-1142. 2004
- Do physicians correctly assess patient symptom severity in gastro‐oesophageal reflux disease?. Alimentary Pharmacology and Therapeutics. 20:1161-1169. 2004
- Does Helicobacter pylori infection and its eradication have any effect on heartburn and gastroesophageal reflux?. Nature Reviews Gastroenterology and Hepatology. 1:16-17. 2004
- International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 20:891-898. 2004
- Review article: gastric pH — the most relevant predictor of benefit in reflux disease?. Alimentary Pharmacology and Therapeutics. 20:19-26. 2004
- Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia. Alimentary Pharmacology and Therapeutics. 20:40-47. 2004
- The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. (vol 17, pg 1481, 2003). Alimentary Pharmacology and Therapeutics. 20:702-702. 2004
- Corrigenda. Alimentary Pharmacology and Therapeutics. 20:702-702. 2004
- The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting. American Journal of Gastroenterology. 99:1238-1246. 2004
- Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 53:iv1-iv24. 2004
- Do we need a new gastro‐oesophageal reflux disease questionnaire?. Alimentary Pharmacology and Therapeutics. 19:463-479. 2004
- Economic evaluation of Helicobacter pylori eradication in the CADET‐Hp randomized controlled trial of H. pylori‐positive primary care patients with uninvestigated dyspepsia. Alimentary Pharmacology and Therapeutics. 19:349-358. 2004
- Peripheral intravenous infusion of potassium chloride: Effect of solution composition on infusion-site pain. Canadian Journal of Hospital Pharmacy. 57:27-31. 2004
- A Canadian Clinical Practice Algorithm for the Management of Patients with Non-Variceal Upper Gastrointestinal Bleeding. Canadian Journal of Gastroenterology and Hepatology. 18:605-609. 2004
- A comparison of narrative and table formats for presenting hypothetical health states to patients with gastrointestinal or pulmonary disease. Medical decision making. 24:53-60. 2004
- Canadian Helicobacter Study Group Consensus Conference: Update on the Management ofHelicobacter pylori- An Evidence-Based Evaluation of Six Topics Relevant to Clinical Outcomes in Patients Evaluated forH pyloriInfection. Canadian Journal of Gastroenterology and Hepatology. 18:547-554. 2004
- Evaluation of GERD Symptoms during Therapy. Part I. Digestion. 69:229-237. 2004
- Evaluation of GERD Symptoms during Therapy. Part II. Digestion. 69:238-244. 2004
- Injection of Botulinum Toxin a to Upper Esophageal Sphincter for Oropharyngeal Dysphagia in Two Patients with Inclusion Body Myositis. Canadian Journal of Gastroenterology and Hepatology. 18:397-399. 2004
- The Construction of a New Evaluative GERD Questionnaire – Methods and State of the Art. Digestion. 70:71-78. 2004
- Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary Pharmacology and Therapeutics. 18:705-711. 2003
- Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Alimentary Pharmacology and Therapeutics. 18:705-711. 2003
- Pantoprazole Rapidly Improves Health-Related Quality of Life in Patients With Heartburn. Journal of Clinical Gastroenterology. 37:132-138. 2003
- The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Alimentary Pharmacology and Therapeutics. 17:1481-1491. 2003
- The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study. Alimentary Pharmacology and Therapeutics. 17:1481-1491. 2003
- GERD 2003 – A Consensus on the Way Ahead. Digestion. 67:111-117. 2003
- Validation of the GSFQ, a Self-Administered Symptom Frequency Questionnaire for Patients with Gastroesophageal Reflux Disease. Canadian Journal of Gastroenterology and Hepatology. 17:307-312. 2003
- Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. European Journal of Gastroenterology and Hepatology. 14:857-863. 2002
- Early relief of upper gastrointestinal dyspeptic symptoms: A survey of empirical therapy with pantoprazole in Canadian clinical practice. Canadian Journal of Gastroenterology and Hepatology. 16:443-454. 2002
- Early Relief of Upper Gastrointestinal Dyspeptic Symptoms: A Survey of Empirical Therapy with Pantoprazole in Canadian Clinical Practice. Canadian Journal of Gastroenterology and Hepatology. 16:439-450. 2002
- Effect of Omeprazole on Regional and Temporal Variations in Intragastric Acidity. Digestion. 65:2-10. 2002
- Motion – All Patients with GERD Should Be Offered Once in a Lifetime Endoscopy: Arguments for the Motion. Canadian Journal of Gastroenterology and Hepatology. 16:549-551. 2002
- Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.. American Journal of Gastroenterology. 96:2849-2857. 2001
- Re: Ammonia cannot explain the effect of H-pylori on omeprazole-induced acid suppression - Response to Dr. McColl et al.. American Journal of Gastroenterology. 96:602-604. 2001
- Gastric acidity and preneoplastic/neoplastic changes of the stomach.. European Journal of Gastroenterology and Hepatology. 12:1353-1354. 2000
- Reply to: Gastric acidity and preneoplastic/neoplastic changes of the stomach. European Journal of Gastroenterology and Hepatology. 12:1354-1354. 2000
- Update from the Canadian Dyspepsia Working Group.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:696. 2000
- Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease. The Lancet. 356:610-612. 2000
- An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. CANADIAN MEDICAL ASSOCIATION JOURNAL. 162:S3-S23. 2000
- An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 162:S3-23. 2000
- The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects. Alimentary Pharmacology and Therapeutics. 14:535-541. 2000
- The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection. American Journal of Gastroenterology. 95:947-955. 2000
- The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach. European Journal of Gastroenterology and Hepatology. 12:165-173. 2000
- Test-and-Treat Strategies forHelicobacter pyloriin Uninvestigated Dyspepsia: A Canadian Economic Anaylsis. Canadian Journal of Gastroenterology and Hepatology. 14:379-388. 2000
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 45:172-180. 1999
- Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 161:154-160. 1999
- Endoscopic evaluation of gastro-esophageal reflux disease.. Yale Journal of Biology and Medicine. 72:93-100. 1999
- Management of Nonsteroidal Anti‐Inflammatory Drug‐Induced Gastroduodenal Disease by Acid Suppression. Canadian Journal of Gastroenterology and Hepatology. 13:135-142. 1999
- High Concentrations of Ammonia, But Not Volatile Amines, in Gastric Juice of Subjects with Helicobacter pylori Infection. Helicobacter. 3:97-102. 1998
- Letters to the Editors. Alimentary Pharmacology and Therapeutics. 12:395-396. 1998
- Omeprazole for Refractory Gastroesophageal Reflux Disease during Pregnancy and Lactation. Canadian Journal of Gastroenterology and Hepatology. 12:225-227. 1998
- The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts. Canadian Journal of Gastroenterology and Hepatology. 12:551-556. 1998
- Reflux esophagitis and H. pylori.. Gastroenterology. 113:2020-2021. 1997
- Efficacy of H2 receptor antagonists in the treatment of gastroesophageal reflux disease and its symptoms.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:51B-54B. 1997
- The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:7B-20B. 1997
- Omeprazole--a new formulation.. Canadian Journal of Gastroenterology and Hepatology. 11:655-656. 1997
- Helicobacter pylori infection and omeprazole efficacy. Gastroenterology. 111:1401-1403. 1996
- Effects of misoprostol on healing and prevention of biopsy‐induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers. Alimentary Pharmacology and Therapeutics. 10:563-569. 1996
- The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology. 111:85-92. 1996
- Helicobacter pyloriInfection and Dyspepsia. Scandinavian Journal of Gastroenterology, Supplement. 31:38-47. 1996
- Erratum: Effects of misoprostol on healing and prevention of biopsy-induced gastroduodenal lesions occurring during the administration of diclofenac to volunteers. Alimentary Pharmacology and Therapeutics. 10:833. 1996
- Helicobacter pylori in the pathogenesis of disease. American Journal of Roentgenology. 166:209-210. 1996
- Infection with Helicobacter pylori.. American Journal of Roentgenology. 166:209-210. 1996
- Intragastric pH during Treatment with Omeprazole: Role ofHelicobacter pyloriandH. pylori-Associated Gastritis. Scandinavian Journal of Gastroenterology, Supplement. 31:1151-1156. 1996
- Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.. Gut. 37:743-748. 1995
- Endoscopic Features of Helicobacter pylori-Related Gastritis. Endoscopy. 27:593-596. 1995
- Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group.. Zeitschrift für Gastroenterologie. 33:509-512. 1995
- FUNCTIONAL DYSPEPSIA - APPROACH FOR HELICOBACTER THERAPY. Leber, Magen, Darm. 25:112-&. 1995
- [Functional dyspepsia: approaches to Helicobacter pylori eradication therapy].. Leber, Magen, Darm. 25:112-120. 1995
- Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole.. Gut. 36:539-543. 1995
- The Origin of Nocturnal Intragastric pH Rises in Healthy Subjects. Scandinavian Journal of Gastroenterology, Supplement. 30:935-943. 1995
- Gastroesophageal reflux disease, pH monitoring, and treatment. Current Opinion in Gastroenterology. 10:426-438. 1994
- RUDER—A prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. Digestive Diseases and Sciences. 39:1425-1433. 1994
- Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.. Gut. 35:455-460. 1994
- Origins of motility patterns in isolated arterially perfused rat intestine. Gastroenterology. 106:649-657. 1994
- Gastric mucosal toxicity of duodenal juice constituents in the rat. Digestive Diseases and Sciences. 39:327-339. 1994
- Effects of Omeprazole and Lansoprazole on 24-Hour Intragastric pH in Helicobacter pylori-Positive Volunteers. Scandinavian Journal of Gastroenterology, Supplement. 29:1065-1069. 1994
- Reflux Disease and Barrett's Oesophagus. Endoscopy. 26:9-19. 1994
- Nocturnal oesophageal motor activity is dependent on sleep stage.. Gut. 34:1653-1659. 1993
- Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group.. Gut. 34:1319-1326. 1993
- Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.. Gut. 34:1025-1031. 1993
- Does long-term maintenance therapy with ranitidine affect the natural course of duodenal ulcer disease?. European Journal of Gastroenterology and Hepatology. 5:311-318. 1993
- CONTINUOUS MEASUREMENT OF RAT GASTRIC BLOOD-FLOW USING DOPPLER FLOWMETER. American Journal of Physiology. 264:G686-G692. 1993
- Continuous measurement of rat gastric blood flow using Doppler flowmeter. American Journal of Physiology. 264:G686-G692. 1993
- Diagnosis and assessment of gastro-oesophageal reflux disease. Gullet. 3:31-41. 1993
- RELAPSE PROPHYLAXIS OF ULCER DISEASE - INDICATION AND CHOICE OF PROCEDURE. Therapeutische Umschau. Revue therapeutique. 49:761-775. 1992
- [Prevention of recurrence of ulcer disease: indications and choice of procedure].. Therapeutische Umschau. Revue therapeutique. 49:761-775. 1992
- Gastroesophageal reflux disease, pH monitoring, and treatment. Current Opinion in Gastroenterology. 8:562-572. 1992
- ESOPHAGEAL PH-METRY - SHOULD MEALS BE STANDARDIZED. Scandinavian Journal of Gastroenterology. 27:350-354. 1992
- The effect of continuous enteral nutrition on gastric acidity in humans. Gastroenterology. 102:1506-1515. 1992
- Maintenance therapy: Is there still a place for antireflux surgery?. World Journal of Surgery. 16:300-307. 1992
- Gastroenterology: Non-peptic diseases. Medecine et Hygiene. 50:216-232. 1992
- Gastroenterology: Peptic diseases. Medecine et Hygiene. 50:206-214. 1992
- Hepatology. Medecine et Hygiene. 50:233-245. 1992
- Influence of Stress on the Healing and Relapse of Duodenal Ulcers: A Prospective, Multicenter Trial of 2109 Patients with Recurrent Duodenal Ulceration Treated with Ranitidine. Scandinavian Journal of Gastroenterology, Supplement. 27:917-923. 1992
- Liver and bile duct diseases. Progress report 1991. Therapiewoche Schweiz. 8:443-463. 1992
- Non-peptic lesions. Advancements in 1991. Therapiewoche Schweiz. 8:371-394. 1992
- Oesophageal pH-Metry: Should Meals Be Standardized?. Scandinavian Journal of Gastroenterology, Supplement. 27:350-354. 1992
- Peptic lesions. Therapiewoche Schweiz. 8:199-219. 1992
- Reflux Disease and Barrett's Oesophagus. Endoscopy. 24:9-17. 1992
- Computer-assisted ambulatory long-term manometry of tubular esophagus. Digestive Diseases and Sciences. 36:90S-97S. 1991
- Gastroesophageal reflux disease and pH monitoring. Current Opinion in Gastroenterology. 7:545-556. 1991
- Reproducibility of long-term ambulatory esophageal combined pH/manometry. Gastroenterology. 100:1630-1637. 1991
- Diclofenac delays healing of gastroduodenal mucosal lesions. Digestive Diseases and Sciences. 36:594-600. 1991
- FAMOTIDINE SHOULD BE TAKEN WITH SUPPER - THE EFFECT OF DRUG MEAL INTERACTIONS ON GASTRIC-ACIDITY AND PLASMA FAMOTIDINE LEVELS. European Journal of Gastroenterology and Hepatology. 3:405-412. 1991
- RUDER: interim evaluation of a 2-year, multicentre study of risk factors for duodenal ulcer relapse.. Zeitschrift fur Gastroenterologie. Verhandlungsband. 26:171-172. 1991
- Advancements in the treatment of peptic lesions during 1990. Therapiewoche. 41:929-952. 1991
- Gastroenterolgy. 1. Peptic lesions. Medecine et Hygiene. 49:222-232. 1991
- Gastroenterology. 2. Non-peptic lesions. Medecine et Hygiene. 49:233-245. 1991
- Hepatology. Medecine et Hygiene. 49:246-257. 1991
- Liver and biliary tract disease: Advances in 1990. Therapiewoche Schweiz. 7:390-408. 1991
- Liver and biliary tract diseases: Advances in 1990. Therapiewoche. 41:1339-1364. 1991
- New perspectives in peptic esophagitis. Medecine et Hygiene. 49:210-221. 1991
- Non-peptic lesions: Progress report 1990. Therapiewoche Schweiz. 7:319-335. 1991
- Peptic lesions: progress report 1990. Therapiewoche Schweiz. 7:225-242. 1991
- Therapeutic advancements during 1990: Non-peptic lesions. Therapiewoche. 41:1133-1158. 1991
- Endoscopic assessment of oesophagitis. Gullet. 1:63-67. 1990
- 24-HOUR PATTERN OF ESOPHAGEAL MOTILITY IN ASYMPTOMATIC VOLUNTEERS. Digestive Diseases and Sciences. 35:1190-1197. 1990
- Twenty-four-hour pattern of esophageal motility in asymptomatic volunteers. Digestive Diseases and Sciences. 35:1190-1197. 1990
- Ambulatory Esophageal Manometry: Comparison of Expert and Computer‐Aided Analyses. Neurogastroenterology and Motility. 2:216-223. 1990
- CONTINUOUS LONG-TERM GASTRIC PH-METRY - FURTHER SUGGESTIONS FOR OPTIMIZING DATA-ANALYSIS - REPLY. European Journal of Gastroenterology and Hepatology. 2:320-323. 1990
- Fate of antacid gel in the stomach. Digestive Diseases and Sciences. 35:553-558. 1990
- Ambulatory esophageal manometry: Comparison of expert and computer-aided analyses. Neurogastroenterology and Motility. 2:216-223. 1990
- Digestive system function disorders: Physiopathologic approach. 1. Introduction, chest pain, and dyspepsia. Medecine et Hygiene. 48:225-232. 1990
- Digestive system function disorders: Physiopathologic approach. 2. Irritable bowel and constipation. Medecine et Hygiene. 48:233-239. 1990
- Gastroenterology. 1. Peptic disorders. Medecine et Hygiene. 48:240-248. 1990
- Gastroenterology. 2. Non-peptic disorders. Medecine et Hygiene. 48:249-260. 1990
- Non-peptic lesions: Advancements during 1989. Therapiewoche Schweiz. 6:361-383. 1990
- Peptic lesions: Progress during 1989. Therapiewoche Schweiz. 6:167-186. 1990
- Reproducibility of Ambulatory Gastric pH Recordings in the Corpus and Antrum: Effect of Food, Time, and Electrode Position. Scandinavian Journal of Gastroenterology, Supplement. 25:1076-1083. 1990
- The short-term treatment of peptic lesions. Therapiewoche. 40:1107-1129. 1990
- Review twenty-four-hour intragastric pH-metry studies: Easy to do but difficult to analyse. European Journal of Gastroenterology and Hepatology. 1:167-174. 1989
- Is the ex vivo rat gastric chamber model suitable for studying the gastrotoxicity of refluxed duodenal contents? Initial results using deoxycholic acid. Clinica Chimica Acta. 178:313-325. 1988
- Sequential endoscopy and biopsy of intact rat stomach. Digestive Diseases and Sciences. 33:321-323. 1988